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Abstract 
Tissue engineering and regenerative medicine represent the collection of all engineering disciplines 
brought together for the common goal of developing novel ways of growing tissues and organs in the 
laboratory. Efforts have made it possible to replicate or induce growth of 2D structures in the human 
body like skin, but the clinical need for on-demand solid organs has yet to be met due to lack of 
understanding of the variables responsible for organogenesis. Cell-colony heterogeneity, 3D-cellular 
architecture, bioactive molecules, and crosstalk communication between parenchymal cell populations 
need to be further investigated, and high-throughput technologies can rapidly increase the rate at which 
screening assays can be conducted and analyzed. Having more comprehensive data that can be 
disseminated in a matter of minutes poses a great advantage for developing more efficacious drug 
treatments and disease models, as well as more functionalized organ models that can be implanted. 
Many high-throughput micro-array systems have been engineered to investigate how cellular micro-
environments and cell-cell and cell-matrix interactions contribute to key physiological events, and how 
we can manipulate them to induce the correct tissue formation and function in vivo. Here we present a 
2D and 3D micro-array cell culture paradigm using elastomeric assembly substrates with micro-droplet 
deposition via microfluidic-aerosol spraying. Production of large area living cell micro-arrays in three 
dimensions is possible through hydrogel photo-encapsulation of cells, producing tunable porous 
matrices that can help elucidate key mechano-transduction pathways influencing cell adhesion, 
proliferation, differentiation, and apoptosis in many tissue-engineering sub-fields like organogenesis, 
drug-screening, and connective tissue diseases.  
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I. Introduction  
I.1 Introduction to Tissue Engineering  
The field of tissue engineering arises from a clinical need to repair or replace malfunctioning tissues in 
the human body and fulfill the global demand for solid organ transplants.28 Currently, the most viable 
option for treatment of organ failure is to get a donor-patient transplant, but it comes at the cost of life-
long immunosuppression and potential rejection.26 More than a quarter million people need a solid 
organ transplant in the U.S. alone, and more than 75% of those cases are for a kidney transplant.29 
Tissue engineering and regenerative medicine are at the forefront of in vitro engineering of organs de 
novo and inducing organ re-growth in situ.26,27,28 These endeavors require special considerations for the 
cell types needed for a particular tissue (stem cells or progenitor cells), scaffolding, and bioactive 
molecules that serve as cues for proper cellular differentiation.28 Our understanding of the chemical, 
mechanical, and immunological processes that happen at the cell-level continue to improve, but the rate 
at which it does is far too slow still to grasp the complexity of engineering whole-organs de novo.26,28  
Therefore, there is a great need for high-throughput technologies that can accelerate the rate of assay 
and diagnostic tool development in the biomedical engineering field.26 Some of the most significant 
advancements in tissue engineering include transplanting simple 2D, tubular, and hallow non-tubular 
organs into patients, restoring the function of damaged blood vessels, replacing malfunctioning 
bladders, and expanding 2D cell-cultures of skin progenitor cells for grafting onto patients with severe 
burn injuries.28 However, as the field stands today, we have yet to produce fully functional “off-the-
shelf” complex organs characteristic for their complex 3D architectures, complex biochemical profiles, 




I.2 Cell Type & Bioactive Molecules  
Cell type and signaling molecules present in the cellular micro-environment constitute the material from 
which the actual tissue is going to be engineered; while the scaffold provides the structure, the cells and 
their signaling molecules contribute to the function of the tissue.27 All tissues are made up of specific 
cells or cell types that together perform all the metabolic activities of a particular tissue and figuring out 
the exact composition of cells, spatial organization, and bioactive molecules needed to induce 
organogenesis is still poorly understood.28 Stem cell research is immensely beneficial to tissue 
engineering because these cells are undifferentiated, and thus they can be coaxed into committing to 
many different lineages.33 These cells can be found in early blastocysts as totipotent embryonic stem 
cells (ESC) and in tissue-specific niches in adult tissue such as multipotent mesenchymal stem cells 
(MSC).36 The degree of “stemness” be defined as totipotent, pluripotent, multipotent, or induced 
pluripotent; totipotent cells can go on to differentiate into all cell types in the body and the placenta, 
pluripotent can differentiate into all cell types in the body, and multipotent can differentiate into a 
limited number of progenitor cells associated with certain germ layers (endoderm, mesoderm, and 
ectoderm).33,36 Also, in the early 2000’s fibroblasts were successfully reprogrammed to regain 
pluripotent stemness, hence the name induced pluripotent stem cells (iPSC).37 The decision on the type 
of stem cell needed for a particular application varies widely and they all have their advantages and 
disadvantages.36 For example, liver organoids have been engineered with both autologous cells + ESC 
which show mature phenotype but are difficult to expand in culture, and with ESC + iPSC which self-
organize in culture and expand considerably but they do not express a mature phenotype.31 
Bioactive signaling molecules -cytokines and chemokines - participate in a wide variety of signal 
transduction pathways in different cell types, making precise identification of key regulatory processes 
in the cell difficult to understand.28,33 However certain cytokines, specifically termed growth factors (GF), 
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are known to have definitive stem cell commitment properties such as bone morphogenic protein (BMP) 
in osteogenesis and vascular endothelial growth factor (VEGF) in neovascularization of tissue and cancer 
metastasis.32,34 GF participate in multi-step signal transduction pathways mediated by highly conserved 
receptor-ligand interactions that lead to a cascade of gene expression and epigenetic events that begin 
the commitment process of stem cells to more differentiated lineages as is the case with the osteogenic 
transduction pathway of BMP converging at the Runx2 gene to initiate precursor cell differentiation in 
MSC.34 Current models have been successful at engineering less-complex tissues with flat, tubular, and 
hollow-viscous structures, but modeling fully functional solid organs is still not possible due to lack of 
comprehensive data with respect to existing protocols for cell culture and differentiation, 3D scaffolding, 
and spatiotemporal arrangement of GF.28  
I.3 Natural & Synthetic Scaffolds  
Scaffolding of the cell is an integral criteria of tissue engineering designs that dictates the fate of stem 
cell differentiation via cell-matrix interactions associated with scaffold mechanical properties.23,25 The 3-
dimensional nature of cell scaffolding allows for complex architectures representative of solid organs to 
be achieved for investigational purposes, and these architectures more accurately represent 
physiological events in vivo; it has been shown that 2D cell culture of cancer cells can influence the 
response to treatment, cell-matrix interactions, polarity, morphology, and skew the data in translation 
to 3D biological systems.30 In the biomedical engineering field, two main kinds of scaffolds are used: 
natural and synthetic, to accomplish 3D cell culture of cells.24  
Natural scaffolds are derived from decellularized animal tissues (xenografts) or decellularized human 
tissues (allografts) and nearly every tissue in the body has been decellularized.23,24 Following extensive 
decellularization with detergents, what is left behind is the extracellular matrix (ECM) made primarily 
from collagen, fibrin, proteoglycans (PGs), and glycosaminoglycans (GAGs) that retain the mechanical, 
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rheological, and anisotropic properties that stem cells can recognize upon re-seeding.28,23 Mechano-
sensing at the ECM interface guides stem cells to differentiate into the correct lineage, and polar groups 
present in GAG chains can capture water soluble bioactive molecules, through physical and weak 
intermolecular forces, that act as growth, proliferation, differentiation, and apoptosis factors critical for 
spatiotemporal organization of the tissue.23 Highly conserved cell-signaling motifs in the ECM scaffold 
also allow re-seeded stem cells to attach, modify, and degrade the ECM environment to replicate the 
complex architecture characteristic of tissues in vivo.23,27,28 For example, collagen’s highly conserved 
arginine-glycine-aspartate (RGD) sequence promotes cell attachment to the scaffold by stimulating 
integrin-mediated focal adhesion formation that subsequently leads to cell spreading, viability, 
proliferation, and osteogenesis in MSC.5 Despite having a biomimetic ECM scaffold with all the correct 
cell-signaling cues for tissue engineering, there are concerns with respect to batch heterogeneity, 
immunogenic cellular remnants post decellularization, and toxic detergent usage that hinders naturally 
derived ECM scaffolds from being the runaway winner in for most favorable type of scaffold to use in 
tissue engineering.23,24  
Synthetic polymer-based scaffolds are an expanding field focused on emulating ECM properties with 
knowledge about polymer network dynamics.9,25 Hydrogels are a special class of polymers that swell 
under aqueous conditions, and they are attractive alternatives to ECM-derived scaffolds due to their 
tunable mechanical properties, degradation rates, porosity, biocompatibility, and structure.9 Polymers 
are composed from monomeric units that form covalent bonds between each other to grow the 
polymer network and they generally crosslink in a chain-growth (one at a time) or step-growth fashion 
(monomers, dimers, trimers, polymers).2,9 Reactive groups at the ends of the monomer units also allow 
for more controlled backbone composition such as homo-polymeric, block, random, alternative, and 
grafted.9 For example, poly- (α-hydroxy esters) like poly-lactic-acid (PLA) and poly-glycolic-acid (PGA) can 
be polymerized to themselves or to each other to form poly-lactic-co-glycolic-acid (PLGA), and 
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monomers like ethylene glycol can be functionalized by the addition of one or two acrylate groups that 
possess carbon-carbon double bonds (C=C) that are susceptible to chemical bond formation.2 Poly-
ethylene-glycol-mono-acrylate (PEGMA) and poly-ethylene-glycol-di-acrylate (PEGDA) can be 
synthesized via photopolymerization whereby a photo-initiator molecule absorbs light in the UV range, 
forms a free radical species that propagates along the acrylate C=C, and creates covalent bonds between 
PEG molecules during chain-growth.2 Biocompatibility of synthetic hydrogels emerges from their relative 
bio-inertness, but as previously mentioned, cells need environmental cues to ensure long-term 
attachment and viability in the matrix.7  Therefore, chemical addition of RGD sequence onto several 
polymer backbones has been successfully done and demonstrated to induce osteogenesis in bone 
marrow stromal cells.5,24  Hybrid molecules such as gelatin methacryloyl (GelMA) can exploit both the 
tunable mechanical properties of synthetic polymers as well as the natural properties of gelatin to 
induce bioactivity in the scaffold.35 There are undoubtedly more variable parameters to consider with 
synthetic hydrogel networks for the purpose of cell scaffolding, and this present both and advantage 
and disadvantage in tissue engineering.9 On one hand, tunable synthetic polymers allow for broader 
applications of scaffolding in tissue engineering, but on the other hand it increases the complexity of the 
system with limited literature available on the topic and potential adverse effects associated with 
foreign body responses of acidic degradation byproducts in vivo.9,25,28  
I.4 Micro-Arrays  
The first generation of micro-array (MA) technologies made ground-breaking advancements to the field 
of genomics and proteomics, and those contributions led to our current understanding of gene 
expression, disease characterization and biomarker identification.19 Inspired by this technology, the 
modern era of high-throughput cellular screening systems are now comprised of miniaturized living cell 
microarrays (LCMA) that house individual cells, groups of cells, or multi-spheroid cellular structures that 
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can be observed and manipulated in order to re-create physiological events; the advantage of using a 
micro-array construct lies in its intrinsic ability to produce thousands of scalable and tunable 
physiological micro-environments where cells can selectively attach, grow, and proliferate as they 
respond to an applied stimulus.12,18 This allows for the screening of thousands of treatment events all in 
one single micro-chip, thus reducing costs, materials, and the need for robust in vitro and in vivo pre-
clinical trials.12,18,19 LCMA have become increasingly important in the field of drug screening, tissue 
engineering, and the study of cell-cell/cell-matrix interactions.12 
The evolution of micro-array technologies from a purely molecular assay tool to a myriad of LCMA 
assembly modalities including but not limited to optical tweezers, magnetic forced-based systems, soft-
lithography, Inkjet printing, and surface chemistry/topography treatments go hand-in-hand with the 
improvements in biomaterial fabrication, contrastable surface chemistry functionalization, 3D printing, 
and microfluidic-integrated systems.1,12 These improvements revolutionized the way stem cells and 
multi-spheroid cellular structures are studied; 2D cell cultures were the standard for cell-culture and 
experimentation, but newly discovered matrices (natural and synthetic) decorated with bioactive 
molecules and perfused with micro-sized channels have been shown to more accurately represent the 
physio-chemical processes occurring in complex 3-dimentional biological systems.10,11 Cutting-edge 
LCMA are currently integrating 3D micro-scaffolding techniques with microfluidic channels to convert 
these static 3D micro-environments into dynamic ones that mimic circulation in the body notable for 
allowing nutrient uptake and waste disposal.12,13  
I.5 Significance of High throughput Single-Cell Micro-Arrays (SCMA) 
SCMA are of particular interest due to the robustness of information that can be gathered from them.1,17 
Most biochemical assays look at colonies of cells, which are not genetically identical.12 Hence, these 
assays rely on the compilation of data averaged across millions of heterogenous cells.12 Having control 
7 
 
over the micro-environments and spatial allocation of single cells in a micro-array allows scientists to 
quantify cell-cell variance and observe cell-cell interactions more closely.1 Cancer is the result of 
uncontrolled cellular division, creating tumor masses comprised of a heterogenous mixture of healthy 
cells and diseased cells, many of which can be found at varying stages along that spectrum.16 Having 
more comprehensive data on cell-to-cell variability in the context of cancer can open the market for 
novel immune-modulatory therapies that can be engineered in bulk by combining genomics and SCMA 
to produce monoclonal antibodies.15,17 The immune system plays a critical role in the progression of 
cancer, and monoclonal antibodies can be manipulated to target malignant cells for destruction via 
adaptive immune responses.12,15 The ramifications of this novel technology have also penetrated the 
realm of organogenesis and organoid engineering.10 Organoid models are created from collections of 
PSC &/or induced pluripotent stem cells (iPSC) that have the potential to differentiate and self-organize 
into organ-like tissues like the intestines, kidneys, and liver.31 Being able to recapitulate early-stage 
physiological events in organogenesis with high-throughput will speed up the process by which we can 
take these miniaturized models of organoids and turn them into accurate disease models or fully 
functional organs.8,11  
I.6.1 Assembly Modalities 
All LCMA technologies work towards the same goal, patterning array surfaces with cellular structures.12 
They work by creating a cell suspension medium that can be deposited on a surface at precise locations 
via a mechanical instrument, or pre-treatment of the array surface by physical or chemical means in a 
geometric fashion to allow selective adhesion of cellular structures.1 All interdisciplinary techniques 
have their advantages and disadvantages, and they vary with respect to the specific application that 
they are being used for.12 Regardless of application, successful LCMA must meet the following criteria: 
provide the physical space for cell attachment and proliferation, create separation between cell-
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containing regions without cross-contamination between colonies, and allow all biological processes to 
go undisturbed by the microarray itself.1,12  
I.6.2 Electro/Magnetic-forced Based MA Systems 
Optical “tweezers” consist of a laser beam focused through a lens objective to produce an optical trap 
via an electric field gradient that can entrap dielectric molecules in a tweezer-like fashion.13 Things like 
cells can be individually manipulated with the optical tweezers to form single-cell MA with sub-micron 
precision and accuracy, and they can be extracted in a likewise fashion.13 Similarly, magnetic force-based 
systems rely on magnetic field gradients that can be used to localize cells at desired array spots; pin-
shaped devices are typically used to concentrate the shape of the magnetic field gradient into magnetic 
hotspots that can pattern the surface in such a way that cells will rally to these spatially defined 
regions.14 To render the cells susceptible to the magnetic field, magnetic molecules that can passively 
diffuse across the cell membrane like magnetite cationic liposomes can be introduced in culture.14 
Sectioning of the MA with electromagnetic forces has been shown to reach single cell resolution with 
fidelity and without further manipulation of the cell-surface interface, allowing for high throughput 
analysis of SCMA under different drug treatments and physical conditions.12,14 However, the 
introduction of magnetic substances into the cell and the radiation produced by optical tweezer beams 
can induce deleterious effects that compromise the viability of the cells under observation, and thus 
skew results during treatment application.13,14  
I.6.3 Inkjet Micro-printing 
Inkjet micro-printing is a very straightforward technique relying on commercially available inkjet printers 
that are outfitted to dispense “bio-inks” of choice onto cell-repelling substrates.21 Inkjet printing is a 
highly automated, contact-free, and drop-on-demand system that allows the user to pattern a surface 
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with relative ease of use, high-throughput, and high spatial resolution (a few hundred microns).20 Early 
use of inkjet bio-printers for MA formation could not print polymer-encapsulated cells due to the 
uncertain fluid mechanics of different bio-inks, evaporation of droplets upon deposition, and increased 
shear stress upon cells during the printing process.26 In 2004, Roth et al., showed successful high-
throughput inkjet printing of collagen-based bio-ink stamps onto which cells could be seeded and 
cultured with high viability.21 However, research on the rheological properties that govern bio-ink 
printing has greatly advanced the field, and focus has been redirected towards the feasibility of printing 
3D structures that allow scaffolding of cells simultaneously upon droplet deposition.20,26 In more recent 
years, Negro et al., demonstrated successful encapsulation of cells in 3D alginate-hydrogel-layered 
matrices that not only promote cell viability and proliferation, but they allow for creation of microfluidic 
channel perfusion via alginate lyase-digestible ink.20 This combination of 3D printing and microfluidic 
channel formation display the integrated systems that would be conducive of practical MA formation 
with the possibility of longevity studies.20 The inexpensive materials, tunable CAD-based designs for 
accurate 3D modeling, and highly flexible bio-ink compositions of inkjet bio-printing continue to bring 
cutting-edge research to the field of high-throughput MA systems with the possibility of delivering single 
cells in complex array formats with co-culture potential, all in picolitre-sized droplets.26 
I.6.4 Surface Chemistry and Soft Lithography  
When creating MA systems, we want cells to interact with a synthetic environment in a way that does 
not alter their function and phenotype.12 Cells interact with their physical environment via integrin 
proteins that form focal adhesions at the cell-matrix interface, and these structures relay information to 
the cell regarding mechanical characteristics of the substrate.1 Literature shows that specific mechanical 
cues or molecules present in the surface can play a critical role in cell attachment, viability, proliferation, 
differentiation, and apoptosis.22 A very common substrate used in these MA assembly techniques 
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polydimethylsiloxane (PDMS), due to its biocompatibility, inertness, good mechanical properties, and its 
easily modifiable surface chemistry from super-hydrophobic into super-hydrophilic; plasma radiation 
can oxidize hydroxyl groups on the PDMS surface that can be further manipulated into a myriad of 
surface chemistry manipulations.1,22 Patterning in these instances is facilitated by stamping, masking, or 
layering of polymers that can be stripped post-treatment, leaving behind micro-contact printed plasma 
regions, self-assembled monolayers (SAMs), or photolithography.22 These micro-patterned regions on 
elastomeric PDMS surfaces allow adsorption of attachment-proteins or motifs that subsequently 
promote cell attachment, viability, and proliferation.1 The high spatial resolution, pushing the echelon of 
tenths of a nanometer, ease of fabrication, and leeway for multi-technique integration make these 
platforms extremely favorable for the study of mechano-transduction.1  In fact, the fabrication of soft 
lithography-based systems that immobilize ligands on patterned PDMS surfaces combined with 
microfluidic channels can provide dynamic systems for investigating cell-cell and cell-matrix interactions 
in migration, apoptosis, differentiation, and cancer-spreading assays.1 
I.7 Research Statement  
In this paper, we explore the development of a LCMA device based on microfluidic deposition of 
airborne-cell-loaded micro-droplets onto soft lithography: micro-contact-printed patterns on 
elastomeric PDMS surfaces. Established cell-assembly protocols on 2D cell culture prompted a transition 
to more comprehensive 3D cell-scaffolding on PEGDA hydrogel matrix. PEGDA was chosen for the 
following reasons:3,4,6  
• Known morphology and mesh size 
• Controlled drug release and protein immobilization upon swelling 
• Ease of manufacture 
• FDA biocompatibility standards 
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• Tunable microsphere size, chain size, and swelling ratio 
• Modifiable acrylate groups to confer bioactivity  
Using this information in combination with our own studies of PEGDA hydrogel dynamics, we can 
determine a set of conditions that works for the assembly of cell loaded PEGDA microdroplets.  
Our versatile cell assembly modality overcomes many of the drawbacks associated with the assembly 
modalities mentioned in previous sections. There is reason to believe that laborious sample preparation 
protocols could influence the reliability of the assembly process, the toxicity of the LCMA to the cell, 
scalability of the MA, and the ability to co-culture cells in a perfusion-based system. The aerosol-
microfluidic device our research group has engineered can overcome these obstacles by using 
commercially available chemicals and products that have no noticeable adverse effects to cell growth, 
viability, and proliferation. Environmental control of the assembly process also maintains conditions that 
are amiable for micro-droplet settling onto the sample and prevent evaporation of newly formed cell 
loaded micro-droplets.1 Scalability of the device is also possible through Poisson distribution analysis of 
pattern surface area in relation to cell loaded micro-droplet sizes that can be deposited on the surface 
for a given mesh size.1 Our group has shown that cell co-culture is also possible through stencil masking 
of the PDMS sample upon micro-droplet deposition, creating fluorescent Nebraska “N” patterns, rows-
column, and square patterns by using two different live-cell-labeling dyes.1 Lastly, the aerosol-
microfluidic device is portable and does not depend on any one specific substrate to create self-
assembled micro-droplets upon spraying, therefore allowing for deposition on elastomeric surfaces or 





II. Materials and Methods 
II.1 Cell Culture 
A431-FRET epidermoid carcinoma cells are cultured, under sterile conditions, in standard DMEM media 
with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S), and they are incubated under at 
37°C and 5% CO2. Cells are grown in T-75 cell-culture flasks to 90-100% confluency and then passaged by 
detachment from the surface with 10% trypsin in phosphate buffered saline (PBS) solution. A passage 
seeding density of 1:50 would be used to re-grow cells, and the rest is harvested and counted via flow 
cytometry (90% trypan blue vol.%) to obtain a working cell density of 10 million cell/mL.  
II.2 Aerosol Device  
A 26-gauge syringe needle is situated on a syringe pump set to dispense 1mL of volume at 60µL/min. To 
create a uniform aerosol profile, a T-junction nozzle with aperture 260 µm is mounted onto the needle 
and compressed Nitrogen air is fed through the line at a constant pressure of 8 psi as the syringe pump 
pushes the plunger at the specified flow rate. A fixed distance of 6 cm is used between the sample and 
the aerosol device and micro-droplet deposition occurs for a duration of 2 mins. The cell suspension 
solution is a composition of DMEM (10% FBS and 1% P/S), 5% glycerol (%volume) and 20mM HEPES 
buffer solution. To determine the aerosol pressure conditions, 3 pressures were investigated with the 
aerosol device at the fixed flow rate of 60µL/min; 34, 48, and 62kPa were tested and cell density 
probability was assessed with fluorescence microscopy of calcein-AM-stained (10mM in PBS) cell-
containing micro-droplets. ImageJ software was used for quantification of cell-containing micro-droplets 




II.3 Sample Preparation  
PDMS is prepared with Sylgard® at a 10:1 ratio of mix. Rectangular substrates are hand-cut to 
dimensions of 0.5X3.5 cm. A mesh polymer mask (300X125µm) is placed directly on top of the samples 
and gently pressed down to ensure uniform contact area and then placed in a vacuum sealed O2 plasma 
oxidation machine for a duration of 3-5 minutes. Hydroxyl-terminated PDMS samples are washed with 
sterile water twice, and deposition of Poly-L-Lysine (PLL) solution at a concentration of 40mM is applied 
for one hour in incubator conditions (5% CO2, >90% humidity, and 37°C). PLL-treated PDMS samples are 
then loaded onto a stretcher bed by clamping both ends of the sample, a 10% strain is placed upon the 
clamped sample, and the stretcher bed is placed on a fixed stage that maintains an orthogonal angle 
with respect to the aerosol spray. Cells were stained with CellTracker in FBS and P/S free media at a 
1:1000 ratio. Fluorescence microscopy and ImageJ software-aided quantitative analysis were used to 
quantify the number of cells per well.  
II.4 Cell Staining and Imaging  
Cells are fixed with 4% formaldehyde for 10 minutes at room temperature in a completely dark room. 
Following two washed with PBS, the samples are treated with 0.1% Triton-X and allowed to incubate 
under the same conditions for 5 minutes. Alexa Fluor 488 dye is used for staining of the actin 
cytoskeleton (diluted to 1:200), and DAPI stain is used for detection of cell nuclei (diluted 1:1000) with 






I.5 Gel Solution Preparation and Cell Photo-encapsulation  
A working solution of PEGDA (M.W. 3400 and 575) is diluted down to 100mg/mL (10 wt.%) along with 
the photo-initiator IC2959 at a final concentration of 1%, with DPBS as the solvent. The solution is then 
filtered sterilized with a 22-µm syringe filter. Once sterile, cells are suspended at a concentration of 10 
million cells/mL, and 1mL of this cell-suspension-gel-solution is drawn up with the syringe for aerosol 
formation and micro-droplet deposition onto oxidized PDMS samples. A 3-head LED UV-lamp with a 
wavelength of 365nm is placed under the sample for crosslinking, and 20W of power are delivered over 
the course of 4 minutes for complete crosslinking and photo-encapsulation of A431-FRET cells.  








Figure 1. Viability of cells in aerosol droplet deposition. B) Probability density distribution of cell-loaded micro-
droplets for different aerosol pressures. C) Fluorescence micrograph of cell-loaded microdroplets labeled with 
green CellTracker. D) Live-dead staining assay after spraying on plasma-treated PDMS surface after 24 hrs. of 
incubation. E) Cell variability measurements for all spraying conditions.1 
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Calcein-AM staining of aerosol-dispelled microdroplets showed that our microfluidic aerosol-based 
device can form cell-loaded microdroplets with high cell viability >90% and average droplet diameter of 
100 µm. Parameterization of the device revealed that working conditions for further assay exploration 
would be optimal at 8psi, 60µL/min, and d = 6cm from sample for a duration of 2 minutes of aerosol 
spray time. Deviation from these parameters usually led to under/over-filling of sample patterns which 
was not conducive of good pattern formation by the deposited cells. The amount of mechanical work 
required by the lab technician also accounted for a lot of variation in precise parameter-setting and 










Figure 2. Surface functionalization. A) Schematic representation of sample preparation. B) Fluorescence imaging of 
hydrophilic regions with FITC-labeling. C) Aqueous micro-droplets assembled on micro-contact printed PDMS 
sample. D) Schematic representation of micro-droplet assembly on functionalized surface. E, F) Probability density 
distribution of number of cells per well for different mesh sizes and cell concentrations. G, H, I) 48 hr. cell growth 
monitoring of 300µm cell array with CellTracker live staining. 1  
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PLL-FITC deposition on wettability-contrast PDMS patterned samples could be made visible through 
fluorescence microscopy, showing green localized geometric regions where the PLL-FITC had adsorbed, 
and demonstrating PDMS oxidation at desired locations with preferential chemical functionalization. 
Strain application during micro-droplet deposition and relaxation post-spraying led to successful 
segregation of micro-droplets on the wettability-contrast surface with moderate bridging between 
micro-droplets. An average of 3 cells per micro-droplet per well were initially deposited and cell viability 
monitoring via CellTracker showed normal cell morphology and proliferation over the course of 48 hrs. 
Not only were we able to successfully confine cell colonies to the desired patterned regions, but cell 
monitoring assays demonstrated that the micro-array assembly and aerosol device did not induce 
chemical or mechanical stresses on the cell that would be detrimental for further investigation of cell 




Figure 3A-3F. cell colony formation during 48 hrs. A, B, C) Fluorescence micrographs showing assembled cells on A, 
B) 125µm patterns and C) 300µm patterns. Nuclei stained with Hoechst (blue) and actin filaments labeled with 
phallotoxins (green). D, E) Heat map (D: 125µm, E: 300µm patterns) showing cell count per well using micrographs 
(A) and (C). F) Distribution of the number of cells per well for the 125µm and 300µm patterns.1 
Actin filament and nucleus staining of the micro-array colonies in combination with ImageJ analysis 
showed that >75% of the pattern regions were filled in and occupied by at least one cell, and cells 
exhibited proper attachment and actin filament orientation, making them assume a spread morphology 
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characteristic of healthy cells. Cell-colony morphology was dictated by the diameter of the patterned 
regions and little bridging was observed between colonies. This multi-variable system could be further 
manipulated to produce SCMA; distance from the sample, cell concentration, spray-time, and size of the 
patterned regions could be adjusted by the user in a myriad of ways to produce a more-than-normal 
number of wells containing only 1 cell upon micro-droplet deposition. Interplay of these variables is not 
yet completely understood but lowering of cell concentration itself proved to be one way to achieve 
this. 
 
Figure 3G. SCMA monitoring over 48 hr. period.1 
Our SCMA monitoring assay can be easily conducted due to the elegant column/row arrangement of the 
patterned regions that allow the user to record a pattern location in an X-Y coordinate plane and come 
back to it at desired time-intervals. This approach makes for a portable design of LCMA that need not be 
placed in less-than-ideal conditions as would be the case for a 24+ hr time-lapsing assay. Instead, careful 
monitoring of a single mitotic cell splitting into two and then four cells over the course of 48 hrs. can be 










Figure 4. Hydrogel micro-droplet attachment to surface and cell encapsulation within LCMA.  
Deposition of cell loaded PEGDA micro-droplets via the aerosol device demonstrated an acceptable 
degree of wettability contrast between the native PDMS regions and the patterned regions. Diffusivity 
across the gel matrix allowed for calcein-AM viability staining of encapsulated cells and showed cells 
were viable within the first 48 hrs. However, cells maintained a spherical shape due to chemical 
inertness of the PEGDA hydrogel matrix, indicating that although the cells were encapsulated, they were 
not physically attached to the gel surface via integrin transmembrane receptor proteins.  
IV. Discussion  
We investigated and parameterized a working cell assembly technology based on the random deposition 
of cell loaded micro-droplets, via an aerosol device, on patterned wettability-contrast surfaces.1 The 
published results concerning shear-force-balance experienced by the cells during droplet deposition, cell 
density distribution, reliability of pattern wettability contrast, and structural integrity of cells cultured in 
the LCMA served as the basis for our micro-array model validation.1 To expand beyond the possibility of 
being able to pattern cell-colonies whose size and shape is dependent upon the pattern geometry and 
diameter, we demonstrated the flexibility and tunability of our system to produce SCMA that could be 
easily and readily monitored with standard microscopy techniques in a portable fashion. Our next step 
in the investigation of novel LCMA technologies is the transition from a 2D micro-array culture to a 3D 
matrix that mimics in vivo microenvironments at these defined patterned regions. Currently, the extent 
of our research has confirmed that PEGDA gel matrices are inert and although they provide a 3D 
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architecture for cell-encapsulation, they do not possess any cell-attachment-motifs that can ensure 
long-term viability of cells within the network via integrin-mediated pathways. Despite our LCMA 
technology still having some short-comings with respect to optimization and ease-of-use, the current 
model can provide a framework for more comprehensive high-throughput assay investigation of cell-cell 
and cell-matrix interactions that could elucidate biochemical processes and aid our understanding of 
tissue engineering.   
V. Conclusion  
In the last 20 years, the biomedical engineering field has expanded exponentially, but our understanding 
of complex biological systems still remains elusive.12 Building diagnostic tools that can recapitulate 
physiological events and have high throughput potential is essential for tissue engineering of complex 
organs and regenerative medicine.10,27,28 Micro-array technology exists in a myriad of forms to 
accomplish this task, but the endeavor requires integration of many disciplines (mechanical, electrical, 
biological, and computational) that make the system immensely complex and difficult to predict.1,12 
Thus, the scope of investigation is going to play a determining role in the type of assembly modality that 
is most appropriate for any given application. In addition to that, replicating the 3D physiological micro-
environment with the appropriate conditions for cell viability, proliferation, and differentiation, 
patterning them with fidelity, and allowing for perfusion of the MA further constraints the path for 
benchtop-to-bedside diagnostics that are long-term, accurate, and efficient.8,10 Our LCMA research has 
focused on the integration of micro-contact-printing-patterning on elastomeric surfaces with cell-
loaded-hydrogel-micro-droplet deposition via microfluidic-based systems for the creation of wettability-
contrast patterned surfaces.1 Published data shows that the assembly paradigm is facile, inexpensive, 
highly tunable, efficacious, and capable of achieving single-cell resolution, and more recent preliminary 
data suggests that translation to a 3D matrix model is feasible given special considerations for hydrogel 
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fluid mechanics, chain functionalization, and surface chemistry functionalization.1 Current operational 
status of the facile cell assembly device is dependent upon trained laboratory personnel, but instrument 
optimization can bring the whole process to an automated level like contact-free Inkjet printing with 
cell-spatial-resolution comparable to “optical tweezers” and rapid micro-droplet array formation 
characteristic of lithography MA.1 This dynamic cell assembly technology can serve as the platform for 
many other high-throughput assays including but not limited to organogenesis, cell-cell and cell-matrix 
interactions, and cell-cell heterogeneity in drug screening.1  
VI. Future Work 
Future investigation of the 3D PEGDA hydrogel niches for cell encapsulation will involve a 3-step process 
for gel-matrix property characterization, gel micro-droplet attachment to the patterned surfaces, and 
attachment of the cells themselves to the network via functionalization of the PEGDA chain. Information 
about the swelling ratio, stiffness, and cross-linking density of the gel-matrix can give us insight into the 
biomolecule immobilization properties of the network, their diffusivity, and the physical and mechanical 
integrity of the matrix while supporting cell viability over extended periods of time. More importantly 
though, is the successful attachment of the hydrogel micro-droplets to the surface via free-radical 
propagation along the methacrylate “sticky ends” of the PEGDA chain in cohort with methacrylate 
groups present at the patterned surfaces via silane treatment of micro-contact-printed PDMS surfaces. 
Once attachment of the gel micro-droplets has been established and its properties well characterized, 
we will introduce RGD motifs within the network’s backbone to stimulate focal adhesion formation by 
encapsulated cells and improve viability and proliferation. Long-term goals of this project include 
investigation of stem cell differentiation and drug screening using the LCMA with automation of the cell 




1 K. Perez-Toralla, A. Olivera-Torres, M. Rose, R. Yang and S. Morin, in 23rd International 
Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2019, Chemical 
and Biological Microsystems Society, 2019, pp. 134–135. 
2 X. Dai, X. Chen, L. Yang, S. Foster, A. J. Coury and T. H. Jozefiak, Acta Biomater., 2011, 7, 1965–
1972. 
3 S. Lee, X. Tong and F. Yang, Biomater. Sci., 2016, 4, 405–411. 
4 M. D. Nichols, E. A. Scott and D. L. Elbert, Biomaterials, 2009, 30, 5283–5291. 
5 F. Yang, C. G. Williams, D. A. Wang, H. Lee, P. N. Manson and J. Elisseeff, Biomaterials, 2005, 26, 
5991–5998. 
6 J. Zhu, Biomaterials, 2010, 31, 4639–4656. 
7 C. R. Nuttelman, M. C. Tripodi and K. S. Anseth, Matrix Biol., 2005, 24, 208–218. 
8 H. Cui, X. Wang, J. Wesslowski, T. Tronser, J. Rosenbauer, A. Schug, G. Davidson, A. A. Popova and 
P. A. Levkin, Adv. Mater., , DOI:10.1002/adma.202006434. 
9 A. Datta, Chem. Soc. Rev., 2007, 1–107. 
10 M. A. Lancaster and J. A. Knoblich, Science (80-. )., 2014, 345. 
11 P. Kakni, R. Hueber, K. Knoops, C. López-Iglesias, R. Truckenmüller, P. Habibovic and S. 
Giselbrecht, Adv. Biosyst., , DOI:10.1002/adbi.202000126. 
12 R. Jonczyk, T. Kurth, A. Lavrentieva, J.-G. Walter, T. Scheper and F. Stahl, Microarrays, 2016, 5, 11. 
13 U. Mirsaidov, J. Scrimgeour, W. Timp, K. Beck, M. Mir, P. Matsudaira and G. Timp, Lab Chip, 2008, 
8, 2174–2181. 
14 K. Ino, M. Okochi, N. Konishi, M. Nakatochi, R. Imai, M. Shikida, A. Ito and H. Honda, Lab Chip, 
2007, 8, 134–142. 
15 L. M. Weiner, R. Surana and S. Wang, Nat. Rev. Immunol., 2010, 10, 317–327. 
16 D. Öhlund, E. Elyada and D. Tuveson, J. Exp. Med., 2014, 211, 1503–1523. 
17 S. Yamamura, H. Kishi, Y. Tokimitsu, S. Kondo, R. Honda, S. Ramachandra Rao, M. Omori, E. 
Tamiya and A. Muraguchi, Anal. Chem., 2005, 77, 8050–8056. 
18 H. Zhu and M. Snyder, Curr. Opin. Chem. Biol., 2001, 5, 40–45. 
19 F. X. R. Sutandy, J. Qian, C. S. Chen and H. Zhu, Curr. Protoc. Protein Sci., , 
DOI:10.1002/0471140864.ps2701s72. 
20 A. Negro, T. Cherbuin and M. P. Lutolf, Sci. Rep., , DOI:10.1038/s41598-018-35504-2. 
21 E. A. Roth, T. Xu, M. Das, C. Gregory, J. J. Hickman and T. Boland, Biomaterials, 2004, 25, 3707–
3715. 
22 P. Colpo, A. Ruiz, L. Ceriotti and F. Rossi, Adv. Biochem. Eng. Biotechnol., 2010, 117, 109–130. 
23 
 
23 J. M. Aamodt and D. W. Grainger, Biomaterials, 2016, 86, 68–82. 
24 S. Naahidi, M. Jafari, M. Logan, Y. Wang, Y. Yuan, H. Bae, B. Dixon and P. Chen, Biotechnol. Adv., 
2017, 35, 530–544. 
25 E. M. Ahmed, J. Adv. Res., 2015, 6, 105–121. 
26 I. Matai, G. Kaur, A. Seyedsalehi, A. McClinton and C. T. Laurencin, Biomaterials, 2020, 226. 
27 L. G. Griffith and G. Naughton, Science (80-. )., 2002, 295. 
28 A. Atala, F. Kurtis Kasper and A. G. Mikos, Sci. Transl. Med., 2012, 4. 
29 S. G. Tullius and H. Rabb, N. Engl. J. Med., 2018, 378, 1920–1929. 
30 M. Kapałczyńska, T. Kolenda, W. Przybyła, M. Zajączkowska, A. Teresiak, V. Filas, M. Ibbs, R. 
Bliźniak, Ł. Łuczewski and K. Lamperska, Arch. Med. Sci., 2018, 14, 910–919. 
31 S. Nuciforo and M. H. Heim, JHEP Reports, 2021, 3, 100198. 
32 S. Karaman, V. M. Leppänen and K. Alitalo, Dev., , DOI:10.1242/dev.151019. 
33 A. Sobhani, N. Khanlarkhani, M. Baazm, F. Mohammadzadeh, A. Najafi, S. Mehdinejadiani and F. 
S. Aval, Acta Med. Iran., 2017, 55, 6–23. 
34 G. Chen, C. Deng and Y. P. Li, Int. J. Biol. Sci., 2012, 8, 272–288. 
35 I. Pepelanova, K. Kruppa, T. Scheper and A. Lavrentieva, Bioengineering, , 
DOI:10.3390/bioengineering5030055. 
36 N. Prior, P. Inacio and M. Huch, Gut, 2019, 68, 2228–2237. 
37 N. Maherali, R. Sridharan, W. Xie, J. Utikal, S. Eminli, K. Arnold, M. Stadtfeld, R. Yachechko, J. 
Tchieu, R. Jaenisch, K. Plath and K. Hochedlinger, Cell Stem Cell, 2007, 1, 55–70. 
 
